rs1555985649
Variant summary
Our verdict is Pathogenic. Variant got 17 ACMG points: 17P and 0B. PM2PM5PP2PP3_StrongPP5_Very_Strong
The NM_001347721.2(DYRK1A):c.1010C>T(p.Ser337Phe) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. S337P) has been classified as Pathogenic.
Frequency
Consequence
NM_001347721.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 17 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
DYRK1A | NM_001347721.2 | c.1010C>T | p.Ser337Phe | missense_variant | 8/12 | ENST00000647188.2 | NP_001334650.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
DYRK1A | ENST00000647188.2 | c.1010C>T | p.Ser337Phe | missense_variant | 8/12 | NM_001347721.2 | ENSP00000494572.1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 34
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
DYRK1A-related intellectual disability syndrome Pathogenic:2
Likely pathogenic, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Oct 19, 2016 | The p.Ser346Phe variant in DYRK1A was absent from large population studies and h as been detected in one individual with a range of phenotypic manifestations inc luding intellectual disability, seizures and microcephaly (TIDEX study, pers.com m.) It reportedly was not detected in the unaffected parents, which increases th e likelihood that it is pathogenic. A different amino acid change at the same po sition (p.Ser346Pro) has been identified as a de novo variant in 2 individuals w ith intellectual disability, autism, and microcephaly (Bronicki 2015, DDDS 2015) , further supporting that a change at this position may not be tolerated. This i s consistent with computational predictions that suggest an impact to the protei n. Finally, the DYRK1A gene is associated with "DYRK1A-related intellectual disa bility syndrome with all cases reported to date resulting from a de novo variant (https://www.ncbi.nlm.nih.gov/books/NBK333438/). In summary, the available evi dence suggests that the Ser346Phe variant is likely pathogenic. - |
Likely pathogenic, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | May 09, 2023 | The DYRK1A c.1037C>T (p.Ser346Phe) missense variant has not, to our knowledge, been reported in the peer-reviewed literature. However, a different amino acid substitution at the same codon (p.Ser346Pro) has been reported in individuals with DYRK1A-related intellectual disability syndrome (PMID: 25920557; 28053047; 29700199). The p.Ser346Phe variant is not observed in version 2.1.1 or version 3.1.2 of the Genome Aggregation Database. This variant is located in the protein kinase domain of DYRK1A, and functional studies conducted in human cell lines demonstrated that the p.Ser346Phe and p.Ser346Pro variants abolish kinase activity (PMID: 29700199; 30831192). Multiple lines of computational evidence suggest the variant may impact the gene or gene product. This variant was identified in a de novo state. Based on the available evidence, the variant is classified as likely pathogenic for intellectual developmental disorder. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at